Notice: You are viewing an unstyled version of this page. Are you using a very old browser? If so, please consider upgrading

EXPRESS is trying to find out more about mothers expressing breastmilk for very preterm babies

Information for Clinicians

This is a non-blinded randomised controlled trial with parallel design taking place in two tertiary neonatal units as part of a PhD. The entire recruitment and follow up period of the trial will take 22 months to complete and the trial aims to recruit 132 mothers of very preterm infants.

Inclusion Criteria

  • Mother has one or two live infants born at 23+0 to 31+6 gestation
  • Infant/s inpatient on a recruiting neonatal unit
  • Willing and able to give informed consent for participation in the study
  • Aged 18 years or above
  • Infant/s will be less than 4 days of age at time of enrolment
  • Mother intends to express milk for at least 14 days
  • Mother has a device on which she can listen to an MP3 file

Exclusion Criteria

  • No dating scan antenatally
  • Triplet or higher order pregnancy with more than two live born infants

Primary outcome measure

Highest recorded value for 24-hour weight of expressed milk up to and including day 21

Secondary outcome measures

  • Proportion expressing ≥750g milk in any recorded 24-hr period up to & including day 21
  • Average milk weight expressed per minute on day 21
  • Average maternal anxiety score (6 item version of Spielberger State-Trait Anxiety Index: STAI-6)
  • Average maternal distress score (Post-Traumatic Stress Checklist for DSM 5: PCL-5)
  • Proportion exclusive human milk feeding at 36 weeks post-menstrual age
  • Proportion of any human milk feeding at 36 weeks post-menstrual age
  • Proportion exclusive human milk feeding at 4 months' corrected age

Updated: Wednesday, 03 March 2021 16:57 (v2)

Contact us

For more information about EXPRESS, please view the contact details page